EVFCX | SAUPX | EVFCX / SAUPX | |
Total Expense Ratio | 1.40 | 1.00 | 140% |
Annual Report Gross Expense Ratio | 1.47 | 1.00 | 147% |
Fund Existence | 9 years | 29 years | - |
Gain YTD | 3.437 | 2.980 | 115% |
Front Load | N/A | 4% | - |
Min. Initial Investment | 10000 | 1000 | 1,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 48.9M | 2.23B | 2% |
Annual Yield % from dividends | 3.40 | 2.79 | 122% |
Returns for 1 year | 5.98 | 6.22 | 96% |
Returns for 3 years | 16.97 | 19.11 | 89% |
Returns for 5 years | 7.73 | 13.49 | 57% |
Returns for 10 years | 16.53 | 25.67 | 64% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FBTTX | 24.09 | -0.16 | -0.66% |
Fidelity Advisor Biotechnology M | |||
AMIDX | 13.35 | -0.17 | -1.26% |
Amana Developing World Institutional | |||
DNLCX | 50.32 | -0.65 | -1.28% |
BNY Mellon Active MidCap C | |||
RTNCX | 12.84 | -0.17 | -1.31% |
Russell Inv Tax-Managed Intl Eq C | |||
RYSGX | 49.88 | -0.93 | -1.83% |
Rydex S&P SmallCap 600 Pure Growth A |